Text size

Berkshire Hathaway unveiled purchases from Merck, Bristol-Myers and AbbVie in the fourth quarter as it exited Pfizer.
Getty Images
Warren Buffett’s Berkshire Hathaway
has recently made significant changes to its portfolio in addition to purchasing
Verizon Communications
and
Chevron,
and the sale of some
Apple
stock.
In the fourth quarter, Berkshire (scorer:
BRK.B
) added to the positions in
Merck
(MRK),
Bristol-Myers Squibb
(BMY) and
AbbVie
(ABBV) and came out of an investment in
Pfizer
(PFE). Buffett’s company also continued to shrink
Fargo fountains
(WFC) stock and sold all its
PNC financial services
(PNC) shares. Elsewhere, Berkshire bought more
Kroger
(KR) has reduced its investment in
General engines
(GM).
Buffett disclosed the share transactions, among other things, in a form it submitted to the Securities and Exchange Commission.
Berkshire Hathaway did not immediately respond to a request for comment on the investment changes.
The company increased its investments in Merck, Bristol-Myers and AbbVie by 28.1% to 28.7 million shares, 11.2% to 33.3 million shares, and 20% to 25.5 million shares. actions. Berkshire Hathaway sold all of its 3.7 million Pfizer shares in its fourth quarter at the end of the third.
Berkshire Hathaway reduced its stake in Wells Fargo by 59% to 52.4 million shares and sold all of its 1.9 million PNC shares.
Buffett’s company increased its stake in the Kroger store by 34.3%, closing 2020 with 33.5 million shares. Berkshire reduced its GM share by 9.4% to 72.5 million shares.
Inside Scoop is a common feature of Barron that covers the stock transactions of corporate executives and board members – the so-called insiders – as well as large shareholders, politicians and other prominent figures. Due to their privileged status, these investors are required to disclose transactions in shares with the Securities and Exchange Commission and other regulatory groups..
Write to Ed Lin at [email protected] and follow @BarronsEdLin.